The phenotype for each ryanodine receptor disease seems to be unique to the receptor and tissue type; cardiomyopathy is not reported in the phenotypic spectrum of RYR1‐RM; and skeletal myopathy is not reported in the phenotype of RYR2 disease (Olubando et al., 2020). Here, RYR1 is linked to skeletal muscle disorder.